$9.62
0.040.42%
al cierre: Sep 4, 5:00 PM EST
$9.58
-0.0445-0.46%
After hour: Sep 4, 7:29 PM EST
ADMA Biologics Inc
ADMANASDAQ
ADMA Biologics Earnings & Forecasts
ADMA Biologics (ADMA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
ADMA Biologics Guidance
ADMA Biologics (ADMA) publicó su última previsión de agosto 5, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $530M - $560M para el período.
En comparación con la previsión anterior, ADMA Biologics mantenido redujo su previsión de ingresos desde un rango anterior de $530M - $560M.
ADMA Biologics ha emitido 15 actualizaciones de orientación entre el noviembre 9, 2022 y el agosto 5, 2026. During this period, the company raised its outlook 7 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.17 | $0.20 | $0.20 | $0.16 |
| Actual | $0.16 | $0.17 | $0.21 | $0.16 |
| Surprise | -5.88% | -15.0% | +7.50% | 0.00% |
| Revenue | ||||
| Estimate | $126.1M | $140.0M | $139.8M | $130.4M |
| Actual | $124.4M | $114.5M | $139.2M | $134.2M |
| Surprise | -1.34% | -18.2% | -0.46% | +2.96% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.20 | $0.24 | $0.17 | $0.20 |
| Revenue | ||||
| Consensus | $138.5M | $157.1M | — | — |